Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40CGS | ISIN: US4618741098 | Ticker-Symbol:
NASDAQ
04.06.25 | 21:37
12,990 US-Dollar
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
EXOZYMES INC Chart 1 Jahr
5-Tage-Chart
EXOZYMES INC 5-Tage-Chart

Aktuelle News zur EXOZYMES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16.05.eXoZymes Highlights Scalable Biomanufacturing Platform and First Spinout, NCTx, on Grow Everything Podcast339MONROVIA, CALIFORNIA / ACCESS Newswire / May 16, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals...
► Artikel lesen
13.05.eXoZymes reports Q1 results2
EXOZYMES Aktie jetzt für 0€ handeln
12.05.eXoZymes Provides First Quarter 2025 and NCTx Subsidiary Update at 5PM EST Today253Management to host earnings call at 5:00PM Eastern Time, today. MONROVIA, CA / ACCESS Newswire / May 12, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that...
► Artikel lesen
12.05.EXOZYMES INC. - 10-Q, Quarterly Report3
07.05.eXoZymes to Host First Quarter 2025 and Subsidiary NCTx Update on Monday May 12, 2025, at 5PM EST298MONROVIA, CA / ACCESS Newswire / May 7, 2025 / eXoZymes Inc. (NASDAQ:EXOZ) ["eXoZymes"] - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines,...
► Artikel lesen
06.05.eXoZymes Launches Subsidiary, NCTx, to Unlock a Promising Compound for Gut and Liver Health255N-trans-caffeoyltyramine (NCT) is a natural product compound attracting considerable interest from researchers and drug developers for its potential role in healthy liver fat metabolism, gut barrier...
► Artikel lesen
25.04.EXOZYMES INC. - S-8, Securities to be offered to employees in employee benefit plans2
21.04.eXoZymes Inc.: Bringing clarity and precision to the cell-free space by introducing exozymes1
12.04.New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie's Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presiden815New to The Street debuts its inaugural restaurant segment featuring BlackBarn with owner and chef John Doherty NEW YORK CITY, NY / ACCESS Newswire / April 12, 2025 / New to The Street, a leading financial...
► Artikel lesen
11.04.New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BIOVie's Dr. Joe Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice President T494BlackBarn Restaurant NYC on 26th street The premiere restaurant segment with Owner and Head Chef John Doherty NEW YORK CITY, NEW YORK / ACCESS Newswire / April 11, 2025 / New to The Street, a leading...
► Artikel lesen
11.04.New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BioVie's Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presiden385New Segment "Market Bites" Debuts with Chef John Doherty of BlackBarn Showcasing the Culinary Side of Business Leadership NEW YORK CITY, NEW YORK / ACCESS Newswire / April 11, 2025 / New to The Street...
► Artikel lesen
10.04.eXoZymes Inc.: BioClick - an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant2
02.04.EXOZYMES INC. - 8-K, Current Report1
02.04.eXoZymes appoints new chief commercial officer1
02.04.eXoZymes GAAP EPS of -$0.892
02.04.eXoZymes Inc.: eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO121Expanded leadership team as eXoZymes ramps up commercial growth Damien Perriman brings more than two decades of experience in successfully developing and commercializing novel biotechnologies Focus...
► Artikel lesen
02.04.eXoZymes Inc.: eXoZymes Provides Fourth Quarter and Full Year 2024 Update226Management to Host Conference Call Today at 4:30PM Eastern Monrovia, CA, April 02, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that...
► Artikel lesen
31.03.EXOZYMES INC. - 10-K, Annual Report1
29.03.New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc.806Sponsored by The Sustainable Green Team (OTC: SGTM), featuring Kevin Harrington - the ORIGINAL Shark from Shark Tank NEW YORK CITY, NEW YORK / ACCESS Newswire / March 29, 2025 / New to The Street, the...
► Artikel lesen
24.03.New to The Street's FOX Business Show #638 Spotlights Visionary CEOs and Breakthrough Innovations Across Health, AI, and Insurance Featuring BioVie CEO Cuong Do, Roadzen CEO Rohan Malhotra, Lou Basenese's The Big Skinny on eXoZymes, and Banzai CEO Joe Dav450Sponsored by The Sustainable Green Team and Featuring an Exclusive Interview with Former Shark Kevin Harringtonhttps://www.youtube.com/watch?v=EfMWKXgIqrINEW YORK CITY, NY / ACCESS Newswire / March...
► Artikel lesen
Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1